SummaryRMgm-5193
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 35858541 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | Not applicable |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | da Silva CM, Kurup P |
Name Group/Department | Department of Cellular Biology |
Name Institute | University of Georgia |
City | Athens, GA |
Country | USA |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-5193 |
Principal name | Pb-Cre |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not tested |
Gametocyte/Gamete | Not tested |
Fertilization and ookinete | Not tested |
Oocyst | Not tested |
Sporozoite | Not tested |
Liver stage | Evidence presented that LISP2 tagged with Cre recombinase is exported into hepatocytes and that the Cre-recombinase is active in infected hepatocytes |
Additional remarks phenotype | Mutant/mutation CRISPR-mediated insertion/tagging was performed using the CRISPR-RGR technology described for mutant RMgm-4633. Protein (function) |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1003000 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0405300 | ||||||||||||||||||||||||||
Gene product | liver specific protein 2, putative | ||||||||||||||||||||||||||
Gene product: Alternative name | LISP2 | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | Cre recombinase | ||||||||||||||||||||||||||
Details of tagging | C-terminal | ||||||||||||||||||||||||||
Additional remarks: tagging | The mutant expresses LISP2 C-terminal tagged as follows: Pb-Cre parasites were generated by fusing Cre recombinase with an SV40 nuclear localization signal (NLS) and HA tag on the C-terminus of Lisp2 by CRISPR-mediated insertion of these coding sequences in the endogenous pblisp2 genomic locus. CRISPR-mediated insertion/tagging was performed using the CRISPR-RGR technology described for mutant RMgm-4633. | ||||||||||||||||||||||||||
Commercial source of tag-antibodies | |||||||||||||||||||||||||||
Type of plasmid/construct | CRISPR/Cas9 construct: integration through double strand break repair | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | Pb-Cre parasites were generated by fusing Cre recombinase with an SV40 nuclear localization signal (NLS) and HA tag on the C-terminus of Lisp2 by CRISPR-mediated insertion of these coding sequences in the endogenous pblisp2 genomic locus. CRISPR-mediated insertion was performed using the CRISPR-RGR technology described for mutant RMgm-4633. Generation of Pblisp2 CRISPR-RGR plasmid A CRISPR-RGR plasmid for the insertion of Cre recombinase, SV40 NLS, and a 1xHA tag was created using pSL1394 as a base plasmid (Addgene # 129522). A homology-directed repair (HDR) template was constructed that consists of: 1) a 5’ homology arm (5’ HA) comprising 411bp of the 3’ end of the pblisp2 coding sequence, 2) coding sequence for a 2x(GGS) flexible linker, Cre, SV40 NLS, a single HA tag, and a stop codon, and 3) a 3’ homology arm (3’ HA) comprising 306bp of the sequences immediately downstream of pblisp2. Additionally, a Ribozyme-Guide[1]Ribozyme sequence was synthesized as previously described(Walker and Lindner, 2019; RMgm-4633) that expressed two sgRNAs with perfect homology to the targeted region of pblisp2. Distinct and unique promoter and 3’UTR sequences were used for each transcriptional cassette to avoid recombination and removal of Plasmodium sequences in the plasmid. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |